This event took place on November 11, 2021.

Womble Bond Dickinson Regulatory Scientist Dr. Heather Hatcher spoke at a DelawareBio event on November 11, BioBreakfast, where attendees gathered to learn about COVID-19 product approvals and future studies. Dr. Hatcher provided an overview of the FDA clinical trial process and key learnings on successfully working with the agency.

WBD Attorney Kristen Cramer helped facilitate this opportunity, through their participation in DelawareBio.

*This event was not hosted by Womble Bond Dickinson (US) LLP. We encourage all of our attorneys and staff to be actively involved in outside organizations as both leaders and presenters. Dr. Hatcher served as a presenter at this event. Any registration fee for this event was set by the outside organization and not by Womble Bond Dickinson (US) LLP.